Irisin is thought to impact organs and tissues engaged in type 2 diabetes, such as liver and pancreas, by rising IR, but the mechanisms by which it modulates the pancreatic islet activity are still unclear. Here, FNDC5 is linked to type 2 diabetes mellitus.